Who should attend the Think Tank?

Leaders across oncology, including clinicians, researchers, patient advocates, nonprofits, academia, government, and industry partners focused on rare cancers and precision medicine.

Is there a cost to register?

Registration is free for patients, caregivers, nonprofits, physicians, academia, and government. Industry partners and corporate for-profit attendees have a $500 registration fee.

Where is the event being held?

State Room, 60 State Street, Boston, MA, USA.

When does registration close?

Registration remains open until the day of the event and closes at 5:00 PM ET on October 29, 2025.

Will sessions be recorded?

Select sessions will be recorded and published on the event page after the Think Tank.

Visit the registration page at https://targetcancer.org/research/think-tank-advancing-precision-medicine/registration/.

Donate

Home
/
Research
/
Think Tank on Advancing...

Think Tank on Advancing Precision Medicine in Rare Cancers

The Think Tank on Advancing Precision Medicine in Rare Cancers is a highly interactive meeting that brings together clinicians, researchers, industry representatives, advocates, and patients to collaborate on common challenges in rare cancer research and treatment.

Leveraging the successful Think Tank model established through over a decade of TargetCancer Foundation meetings, it creates a collaborative environment where diverse perspectives and ideas thrive. This meeting also builds on the progress made through TargetCancer Foundation’s TCF-001 TRACK study, a nationwide, decentralized, patient-driven clinical trial studying precision medicine in rare cancers.

View past Think Tank agendas and videos.

On October 29, 2025, the 4th Think Tank on Advancing Precision Medicine in Rare Cancers was held in Boston, MA. This event united key stakeholders for a day of interactive discussions on challenges related to rare cancer treatment development and policy. The day began and ended with rare cancer patient and advocacy perspectives, and also focused on potentially paradigm shifting targeted therapy options in tissue-agnostic therapy development, the changing rare cancer funding landscape, and advocacy for rare cancer research policy. For the first time this year, we were also pleased to provide a platform for early career investigators to share their research with invested rare cancer experts . You can view the full agenda and photos from the Think Tank at the links below.

View the 2025 Meeting Agenda

View 2025 Meeting Photos

Thank you to everyone who joined us in Boston on October 29 for the 2025 Think Tank on Advancing Precision Medicine in Rare Cancers.

We look forward to sharing videos and updates from the meeting soon.

Thank You To Our Sponsors

What participants are saying

This was a fantastic #RareCancer #PrecisionMedicine meeting @targetcancer in Boston! So much enthusiasm from patients and patient advocates to move the field forward.

Vivek Subbiah, MD
Sarah Cannon Research Institute
Originally posted on Twitter

This is genuinely the best rare cancer meeting I have ever attended.

Razelle Kurzrock, MD
Froedtert and Medical College of Wisconsin

…thank you for allowing me to be a part of the discussion of challenges, goals, opportunities and best practices in addressing the needs of patients facing rare cancers. What a wonderful group of humans you gathered. I was so inspired.

Katie Ortman Doble
Patient Keynote Speaker,
2023 Think Tank on Advancing Precision Medicine in Rare Cancers

View and download materials from past meetings

2024

Agenda

Photos

Videos

2023

Agenda

Photos

Video

2022

Agenda

Photos

Video

TCF-001 TRACK Live Molecular Tumor Board 2024:
Salivary Duct Carcinoma

Presented at the TargetCancer Foundation Think Tank on Advancing Precision Medicine in Rare Cancers, November 20, 2024, Boston MA

We are grateful to our industry partners for supporting these meetings and for their dedication to developing treatments for patients with rare cancers.